Blood thinner bivalirudin is more effective than heparin with optional use of glycoprotein IIb/IIIa inhibitors in reducing risk of death and major bleeding complications in patients with ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) in a pre-hospital setting, a new study reveals. Findings from the EUROMAX trial were reported today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored ...
Read More
No comments:
Post a Comment